Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 2,303 shares at $16.14 ($37K) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Seasonal sale ($37k) by Chief Operating Officer — this insider has traded NVCR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $330K | — | Filing → |